SRTS
Sensus Healthcare, Inc.
SRTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
SRTS Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Strong |
SRTS's balance sheet is currently strong, but its revenue, profitability and cash flow are weak.
SRTS PE Valuation
SRTS has no meaningful PE right now: it lost money over the past year.
SRTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect SRTS's losses to shrink, with revenue declining. However, they disagree widely on these estimates.
SRTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.94 | -$0.89 |
| Q1 2026 | -$0.47 | -527% |
| Q4 2025 | -$0.47 | -215% |
| Q3 2025 | -$0.18 | -132% |
| Q2 2025 | -$0.05 | -112% |
| Q1 2025 | $0.11 | -62% |
| Q4 2024 | $0.41 | +1267% |
| Q3 2024 | $0.57 | +$0.63 |
SRTS lost $0.94 per share over the past year, a bigger loss than the year before.
SRTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.3M | -69% |
| Q1 2026 | $3.4M | -59% |
| Q4 2025 | $4.9M | -62% |
| Q3 2025 | $6.9M | -22% |
| Q2 2025 | $7.3M | -21% |
| Q1 2025 | $8.3M | -22% |
| Q4 2024 | $13.1M | +4% |
| Q3 2024 | $8.8M | +127% |
SRTS's revenue has slid since its 2022 peak: $2M last quarter, down 69% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -139% | -112 points |
| Q1 2026 | -128% | -97 points |
| Q4 2025 | -64% | -77 points |
| Q3 2025 | -37% | -54 points |
| Q2 2025 | -27% | -48 points |
| Q1 2025 | -32% | -59 points |
| Q4 2024 | 13% | -31 points |
| Q3 2024 | 17% | +66 points |
SRTS's operating margin was −139% last quarter, down 112 points from the same quarter a year ago.
SRTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.1M | -202% |
| Q1 2026 | -$3.8M | -$1.1M |
| Q4 2025 | -$2.4M | -$1.8M |
| Q3 2025 | $2.3M | -37% |
| Q2 2025 | $3.1M | -27% |
| Q1 2025 | -$2.7M | +$5.7M |
| Q4 2024 | -$530K | -120% |
| Q3 2024 | $3.6M | +739% |
SRTS's free cash flow was −$7M over the past year, against $3M the year before.
SRTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -594 shares |
| 1 year | +0.9% | +142K shares |
| 3 years | +1.3% | +212K shares |
| 5 years | +0.1% | +8.5K shares |
| Available history | +0.4% | +64.2K shares |
SRTS has 16M diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $300,000 |
| Q4 2023 | — |
| Q4 2022 | $2M |
| Q3 2022 | — |
SRTS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | -6.8x | Net Cash |
| Q4 2024 | -2.7x | Net Cash |
| Q3 2024 | -1.9x | Net Cash |
| Q2 2024 | -2.2x | Net Cash |
| Q1 2024 | -2.6x | Net Cash |
| Q2 2023 | -7.8x | Net Cash |
| Q1 2023 | -0.5x | Net Cash |
| Q4 2022 | -0.7x | Net Cash |
SRTS has more cash than debt.
SRTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 11.9 | Oversold |
SRTS's weekly RSI is 51 (neutral) and its Stochastic is 12 (oversold).
SRTS PE vs Healthcare Sector
| Metric | SRTS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SRTS has no meaningful PE right now: it lost money over the past year.
SRTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.93 | 9.9% above |
| 20 week MA | $3.03 | 6.3% above |
| 50 week MA | $3.57 | 9.8% below |
| 100 week MA | $4.12 | 22% below |
| 200 week MA | $4.35 | 26% below |
SRTS has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 26% below its 200-week average.
SRTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.38 | $3.91 | +16% |
| 2021 | $3.91 | $8.34 | +113% |
| 2022 | $8.34 | $6.90 | -17% |
| 2023 | $6.90 | $2.36 | -66% |
| 2024 | $2.36 | $7.21 | +206% |
| 2025 | $7.21 | $3.79 | -47% |
| 2026 YTD | $3.79 | $3.22 | -15% |
SRTS's yearly returns have swung widely, from +206% in 2024 to −66% in 2023. It's down 15% so far in 2026.